10-Q
Quarterly Report
SONOMA PHARMACEUTICALS, INC.
SNOA
NASDAQ
CIK: 1367083
File #: 001-33216
Balance Sheet
37 line items · 2 periods
XBRL
| Item | Sep 30, 2024 | Mar 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 4,078,000 | 3,128,000 |
Accounts Receivable | 3,157,000 | 2,898,000 |
Inventory | 2,837,000 | 2,719,000 |
Other Non-Operating Current Assets | 1,929,000 | 3,541,000 |
Current portion of deferred consideration, net of discount | 220,000 | 262,000 |
Total current assets | 12,221,000 | 12,548,000 |
Property, Plant and Equipment | 255,000 | 365,000 |
Operating Lease Right-of-Use Asset | 162,000 | 286,000 |
Deferred Tax Assets, Non-Current | 792,000 | 1,145,000 |
Deferred consideration, net of discount, less current portion | 179,000 | 330,000 |
Other Non-Operating Non-Current Assets | 76,000 | 66,000 |
Total assets | 13,685,000 | 14,740,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 770,000 | 607,000 |
Accounts Payable | 2,022,000 | 2,113,000 |
Other Current Liabilities | 319,000 | 478,000 |
Short-Term Debt | 82,000 | 323,000 |
Operating Lease Liability, Current | 116,000 | 198,000 |
Total current liabilities | 3,309,000 | 3,719,000 |
Warranty and Other Provisions | 45,000 | 87,000 |
Withholding tax payable | 4,933,000 | 4,710,000 |
Operating Lease Liability, Non-Current | 46,000 | 87,000 |
Total liabilities | 8,333,000 | 8,603,000 |
Stockholders’ Equity: | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 0 | 0 |
Total Stockholders' Equity | 205,651,000 | 203,209,000 |
Total Stockholders' Equity | (196,102,000) | (194,349,000) |
Total Stockholders' Equity | (4,197,000) | (2,723,000) |
Total stockholders’ equity | 5,352,000 | 6,137,000 |
Additional Paid-in Capital | 205,651,000 | 203,209,000 |
Retained Earnings | (196,102,000) | (194,349,000) |
AOCI Attributable to Parent | (4,197,000) | (2,723,000) |
Total liabilities and stockholders’ equity | 13,685,000 | 14,740,000 |